| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0889-8588(05)70021-6 |
| P698 | PubMed publication ID | 9759577 |
| P2093 | author name string | J E Gershenwald | |
| M I Ross | |||
| A C Buzaid | |||
| P2860 | cites work | Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma | Q24540048 |
| Minimal-access surgery for staging of malignant melanoma | Q34293947 | ||
| Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. | Q34309669 | ||
| Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. | Q34371245 | ||
| Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system | Q34418926 | ||
| The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. | Q36081848 | ||
| Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. | Q36657059 | ||
| The prognosis of melanoma patients with metastases to two or more lymph node areas | Q37233446 | ||
| Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic | Q37521168 | ||
| Prognostic factors for survival of patients treated systemically for disseminated melanoma. | Q38529290 | ||
| Radionuclide photoscanning. Usefulness in preoperative evaluation of melanoma patients | Q39352893 | ||
| Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients | Q39616273 | ||
| Prognosis for recurrent stage I malignant melanoma | Q39784979 | ||
| Prognostic value of lymph node dissection in malignant melanoma | Q40361763 | ||
| Cost-effectiveness of PET imaging in clinical oncology | Q41240148 | ||
| Recent advances in the care of the patient with malignant melanoma | Q41317571 | ||
| Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes | Q41457969 | ||
| Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma | Q41523597 | ||
| Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction | Q41656564 | ||
| The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients | Q41903179 | ||
| Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study | Q42442688 | ||
| The classification of melanoma and its relationship with prognosis | Q44128845 | ||
| Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis | Q44142692 | ||
| Cutaneous melanoma: prognosis and treatment results worldwide | Q44432993 | ||
| Epidermotropic metastatic melanoma. Are the current histologic criteria adequate to differentiate primary from metastatic melanoma? | Q72910577 | ||
| Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis | Q73021255 | ||
| Computed tomography in evaluation of patients with stage III melanoma | Q73321930 | ||
| Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients | Q73585177 | ||
| Computed tomography in staging of patients with melanoma metastatic to the regional nodes | Q73593433 | ||
| STAGING OF MALIGNANT MELANOMAS BY DEPTH OF INVASION; A PROPOSED INDEX TO PROGNOSIS | Q78437019 | ||
| Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I | Q79052001 | ||
| Metastasis of primary melanoma to two separate lymph node basins: prognostic significance | Q46886112 | ||
| Prognostic value of size of lymph node metastases in patients with cutaneous melanoma | Q47348250 | ||
| Stage I-II melanoma: the value of metastatic work-up | Q48232152 | ||
| Preoperative nuclear scans in patients with melanoma | Q48668972 | ||
| Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians | Q48720555 | ||
| Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. | Q50752731 | ||
| Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. | Q50759657 | ||
| A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods | Q52437315 | ||
| Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. | Q52869672 | ||
| The prognosis of patients with stage III melanoma. Prospective long-term study of 286 patients of the Fachklinik Hornheide. | Q53390864 | ||
| Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma | Q61908907 | ||
| The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage i cutaneous melanoma | Q62711484 | ||
| Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness | Q67362199 | ||
| The Prognostic Implications of Microscopic Satellites in Patients With Clinical Stage I Melanoma | Q67909100 | ||
| Axillary node dissection in malignant melanoma | Q68025832 | ||
| Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis | Q68060950 | ||
| Technical details of intraoperative lymphatic mapping for early stage melanoma | Q68089035 | ||
| Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients | Q68252683 | ||
| Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma | Q68273630 | ||
| The Use of Computed Body Tomography in Malignant Melanoma | Q68350688 | ||
| The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma | Q68617131 | ||
| Prognosis of thick cutaneous melanoma of the trunk and extremity | Q68714211 | ||
| Axillary dissection in melanoma. Prognostic variables in node-positive patients | Q68864789 | ||
| Extent of lymph node dissection in melanoma of the trunk or lower extremity | Q69053768 | ||
| Metastatic disease in patients with newly diagnosed malignant melanoma | Q69074142 | ||
| Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma | Q69465680 | ||
| Prognosis of clinical stage I melanoma patients with positive elective regional node dissection | Q69572888 | ||
| Evaluation of staging workup in malignant melanoma | Q69647193 | ||
| Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases | Q69716711 | ||
| The Role of Groin Dissection in the Management of Melanoma of the Lower Extremity | Q69733861 | ||
| Results of ilioinguinal dissection for stage II melanoma | Q70391886 | ||
| Role of computed tomography in the staging of primary melanoma | Q70671884 | ||
| Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness | Q70709103 | ||
| A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II) | Q70717837 | ||
| Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes | Q70755933 | ||
| Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma | Q71020823 | ||
| "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness | Q71293134 | ||
| Prognosis of skin melanoma with regional node metastases (stage II) | Q71331841 | ||
| Positron emission tomography in the detection and management of metastatic melanoma | Q71690402 | ||
| Prognostic parameters in recurrent malignant melanoma | Q71761060 | ||
| Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma | Q71833014 | ||
| Role of computed tomography in the staging of patients with local-regional metastases of melanoma | Q71961946 | ||
| Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay | Q71961949 | ||
| Local melanoma recurrences in the scar after limited surgery for primary tumor | Q71968804 | ||
| Groin dissection in malignant melanoma | Q72424829 | ||
| Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis | Q72559262 | ||
| Hematogenous spread of malignant melanoma cells in different stages of disease | Q72620694 | ||
| Results of adjuvant interferon study in WHO melanoma programme | Q72673247 | ||
| The orderly progression of melanoma nodal metastases | Q72871409 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 737-765 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Hematology / Oncology Clinics of North America | Q15749192 |
| P1476 | title | Classification and staging of melanoma | |
| P478 | volume | 12 |
| Q91790659 | Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics |
| Q35792651 | Do we need to redefine a cancer metastasis and staging definitions? |
| Q35735559 | Melanoma of the head and neck: current concepts in staging, diagnosis, and management |
| Q38646098 | Principles of Melanoma Staging |
| Q34625447 | Staging and prognosis of cutaneous melanoma |
Search more.